Search

Your search keyword '"Sinilnikova OM"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Sinilnikova OM" Remove constraint Author: "Sinilnikova OM"
138 results on '"Sinilnikova OM"'

Search Results

1. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

2. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

3. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

4. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

5. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

6. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

7. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

8. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

9. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

10. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

11. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

12. Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing

13. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

14. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

15. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

16. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

17. PTEN germ-line mutations in juvenile polyposis coli

18. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

19. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk

20. A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

21. Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

22. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

23. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

24. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

25. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

26. Exploring the link between MORF4L1 and risk of breast cancer

27. Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

28. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

29. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

30. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

31. Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition

32. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

33. Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.

34. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

35. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

36. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

37. GENESIS: a French national resource to study the missing heritability of breast cancer.

38. Mutation analysis of PALB2 gene in French breast cancer families.

39. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

40. Occurrence of a non deleterious gene conversion event in the BRCA1 gene.

41. Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2.

42. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.

43. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

44. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

45. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.

46. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

47. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

48. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.

49. Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing.

50. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

Catalog

Books, media, physical & digital resources